Fund Tracker India by Ishaan Dungarwal
Guide

UTI - Healthcare Fund

Holdings for Oct 2026, changes against Sep 2026, from UTI Mutual Fund's monthly file.

UTI - Healthcare Fund portfolio holdings, Oct 2026: 46 stocks, ₹1,404 cr in listed equity, from UTI Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Kamal Gada

Benchmark: BSE Healthcare TRI · Riskometer: Very High · SEBI category, as filed: Sectoral · Allotted 28 Jun 1999

Source: AMFI scheme summary document

NAV

UTI - Healthcare Fund - Direct Plan - Growth

Source: AMFI

₹401.839820 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹1,399 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.23 %, regular 2.40 % (174 schemes) · Regular costs ₹890 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 1.02 %, regular 1.81 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 20 Nov 2026. Source: AMFI · Glossary: TER

Direct 1.31 %Regular 2.20 %
Equity held

46 stocks, Oct 2026.

Source: UTI Mutual Fund monthly portfolio

₹1,404 cr46 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 46.6%.

98.0%top 10 stocks 46.6%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 12 months to Oct 2026
Nov 2025: equity held ₹1,112 cr, 43 stocks, NAV ₹329.20Dec 2025: equity held ₹1,095 cr, 43 stocks, NAV ₹321.60Jan 2026: equity held ₹1,042 cr, 43 stocks, NAV ₹308.49Feb 2026: equity held ₹1,087 cr, 43 stocks, NAV ₹323.03Mar 2026: equity held ₹1,041 cr, 43 stocks, NAV ₹307.91Apr 2026: equity held ₹1,089 cr, 43 stocks, NAV ₹332.53May 2026: equity held ₹1,149 cr, 42 stocks, NAV ₹349.27Jun 2026: equity held ₹1,243 cr, 42 stocks, NAV ₹371.13Jul 2026: equity held ₹1,318 cr, 43 stocks, NAV ₹380.96Aug 2026: equity held ₹1,361 cr, 43 stocks, NAV ₹392.74Sep 2026: equity held ₹1,346 cr, 44 stocks, NAV ₹379.88Oct 2026: equity held ₹1,404 cr, 46 stocks, NAV ₹375.09
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsJul 2026▲ +6.5%▼ −1.5%
6 monthsApr 2026▲ +28.9%▲ +12.8%
12 monthsOct 2025▲ +27.2%▲ +14.1%
MonthEquity heldStocksNAV at month end
Nov 2025₹1,112 cr43₹329.2006
Dec 2025₹1,095 cr43₹321.5996
Jan 2026₹1,042 cr43₹308.4940
Feb 2026₹1,087 cr43₹323.0324
Mar 2026₹1,041 cr43₹307.9139
Apr 2026₹1,089 cr43₹332.5343
May 2026₹1,149 cr42₹349.2681
Jun 2026₹1,243 cr42₹371.1337
Jul 2026₹1,318 cr43₹380.9617
Aug 2026₹1,361 cr43₹392.7383
Sep 2026₹1,346 cr44₹379.8786
Oct 2026₹1,404 cr46₹375.0929
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New2
  • Added13
  • Trimmed6
  • Exited0
Stocks, by share count · Source: UTI Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    98.0%
  2. Rest, not itemised
    2.0%
Source: UTI Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
  1. 100.0%
Source: UTI Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Small Cap
    42.0%
  2. Mid Cap
    36.0%
  3. Large Cap
    19.6%
  4. Not in AMFI's list
    2.5%
Source: UTI Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 46.6% together
  1. 7.44%
  2. 6.46%
  3. 5.78%
  4. 4.29%
  5. 4.20%
  6. 3.89%
  7. 3.83%
  8. 3.66%
  9. 3.65%
  10. 3.37%
Source: UTI Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

21 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
SMT New—4.47 lakh+4.47 lakh—+₹20.7 cr₹20.7 cr
NATCOPHARM New—1.08 lakh+1.08 lakh—+₹8.4 cr₹8.4 cr
DRREDDY Added6.07 lakh6.13 lakh+5,531+0.9%+₹0.75 cr₹82.8 cr
MAXHEALTH Added4.30 lakh7.00 lakh+2.70 lakh+62.8%+₹23.2 cr₹60.2 cr
APOLLOHOSP Added53,00065,000+12,000+22.6%+₹10.1 cr₹54.9 cr
ALKEM Added1.02 lakh1.03 lakh+17+0.0%+₹0.01 cr₹52.4 cr
LUPIN Added2.04 lakh2.60 lakh+56,166+27.6%+₹11.3 cr₹52.3 cr
MEDANTA Added3.10 lakh3.80 lakh+70,000+22.6%+₹8.9 cr₹48.3 cr
CAPLIPOINT Added1.59 lakh1.65 lakh+5,970+3.8%+₹1.4 cr₹38.4 cr
JLHL Added11.77 lakh12.50 lakh+73,185+6.2%+₹1.9 cr₹32.1 cr
APLLTD Added2.43 lakh3.20 lakh+77,040+31.7%+₹6.1 cr₹25.5 cr
BLUEJET Added3.75 lakh4.50 lakh+75,000+20.0%+₹3.8 cr₹22.7 cr
VIYASH Added8.42 lakh8.92 lakh+50,425+6.0%+₹1.1 cr₹19.5 cr
WINDLAS Added1.86 lakh2.08 lakh+21,549+11.6%+₹1.9 cr₹18.2 cr
LAXMIDENTL Added8.03 lakh9.20 lakh+1.17 lakh+14.5%+₹2.1 cr₹16.3 cr
AJANTPHARM Trimmed1.90 lakh1.75 lakh−15,000−7.9%−₹5.3 cr₹61.4 cr
GLAND Trimmed2.00 lakh1.80 lakh−20,076−10.0%−₹6.2 cr₹55.7 cr
IPCALAB Trimmed2.09 lakh1.89 lakh−19,694−9.4%−₹3.8 cr₹36.4 cr
SUDEEPPHRM Trimmed1.52 lakh1.30 lakh−22,039−14.5%−₹2.4 cr₹13.9 cr
PFIZER Trimmed34,33232,000−2,332−6.8%−₹0.86 cr₹11.8 cr
EMCURE Trimmed15,0004,907−10,093−67.3%−₹1.9 cr₹0.92 cr
Source: UTI Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (46 stocks)

Every listed stock in the month's file, largest first.

largest first, by value
Company Sector
SUNPHARMASun Pharmaceutical Industries Limited Healthcare6.00 lakh₹107 cr7.44%
DIVISLABDivi's Laboratories Limited Healthcare94,707₹92.6 cr6.46%
DRREDDYDr. Reddy's Laboratories Limited Healthcare6.13 lakh₹82.8 cr5.78%
AJANTPHARMAjanta Pharma Limited Healthcare1.75 lakh₹61.4 cr4.29%
MAXHEALTHMax Healthcare Institute Limited Healthcare7.00 lakh₹60.2 cr4.20%
GLANDGland Pharma Limited Healthcare1.80 lakh₹55.7 cr3.89%
APOLLOHOSPApollo Hospitals Enterprise Limited Healthcare65,000₹54.9 cr3.83%
ALKEMAlkem Laboratories Limited Healthcare1.03 lakh₹52.4 cr3.66%
LUPINLupin Limited Healthcare2.60 lakh₹52.3 cr3.65%
MEDANTAGlobal Health Limited Healthcare3.80 lakh₹48.3 cr3.37%
COHANCECohance Lifesciences Limited Healthcare9.00 lakh₹40.0 cr2.79%
CAPLIPOINTCaplin Point Laboratories Limited Healthcare1.65 lakh₹38.4 cr2.68%
IPCALABIPCA Laboratories Limited Healthcare1.89 lakh₹36.4 cr2.54%
JLHLJupiter Life Line Hospitals Limited Healthcare12.50 lakh₹32.1 cr2.24%
MARKSANSMarksans Pharma Limited Healthcare10.00 lakh₹30.6 cr2.14%
GLENMARKGlenmark Pharmaceuticals Limited Healthcare1.30 lakh₹29.8 cr2.08%
AUROPHARMAAurobindo Pharma Limited Healthcare1.77 lakh₹29.7 cr2.08%
RAINBOWRainbow Childrens Medicare Limited Healthcare2.40 lakh₹29.2 cr2.04%
FORTISFortis Healthcare Limited Healthcare3.75 lakh₹28.8 cr2.01%
PGHLProcter & Gamble Health Limited Healthcare50,000₹28.4 cr1.98%
APLLTDAlembic Pharmaceuticals Limited Healthcare3.20 lakh₹25.5 cr1.78%
ANTHEMAnthem Biosciences Limited Healthcare3.00 lakh₹24.9 cr1.74%
ASTERDMAster DM Quality Care Limited Healthcare3.60 lakh₹24.5 cr1.71%
LALPATHLABDr. Lal Path Labs Limited Healthcare1.20 lakh₹22.9 cr1.60%
BLUEJETBlue Jet Healthcare Ltd Healthcare4.50 lakh₹22.7 cr1.58%
BIOCONBiocon Limited Healthcare6.25 lakh₹22.0 cr1.53%
METROPOLISMetropolis Healthcare Limited Healthcare3.87 lakh₹21.1 cr1.47%
CIPLACipla Limited Healthcare1.50 lakh₹20.7 cr1.44%
SMTSahajanand Medical Technologies Limited Healthcare4.47 lakh₹20.7 cr1.44%
VIYASHViyash Scientific Limited Healthcare8.92 lakh₹19.5 cr1.36%
VIJAYAVijaya Diagnostic Centre Limited Healthcare1.32 lakh₹19.1 cr1.34%
SAILIFESai Life Sciences Limited Healthcare1.18 lakh₹18.4 cr1.28%
WINDLASWindlas Biotech Limited Healthcare2.08 lakh₹18.2 cr1.27%
LAXMIDENTLLaxmi Dental Limited Healthcare9.20 lakh₹16.3 cr1.14%
ERISEris Lifesciences Limited Healthcare1.35 lakh₹15.6 cr1.09%
MANIPALHOSManipal Health Enterprises Ltd Healthcare2.13 lakh₹14.2 cr0.99%
SUDEEPPHRMSudeep Pharma Limited Healthcare1.30 lakh₹13.9 cr0.97%
AARTIPHARMAarti Pharmalabs Limited Healthcare1.50 lakh₹13.1 cr0.91%
PFIZERPfizer Limited Healthcare32,000₹11.8 cr0.82%
SANOFICONRSanofi Consumer Healthcare India Limited Healthcare25,262₹8.7 cr0.61%
ORCHPHARMAOrchid Pharma Limited Healthcare1.01 lakh₹8.5 cr0.59%
NATCOPHARMNatco Pharma Limited Healthcare1.08 lakh₹8.4 cr0.59%
JUBLPHARMAJubilant Pharmova Limited Healthcare89,675₹8.3 cr0.58%
INDGNIndegene Limited Healthcare1.20 lakh₹7.0 cr0.49%
SYNGENESyngene International Limited Healthcare1.63 lakh₹6.6 cr0.46%
EMCUREEmcure Pharmaceuticals Limited Healthcare4,907₹0.92 cr0.06%
Show all 46 stocksShow the first 15

Equity rows as disclosed, Oct 2026. Source: UTI Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202619.2%35.3%41.1%2.4%Jun 2026
Sep 202618.2%33.6%41.2%1.1%Jun 2026
Aug 202619.2%33.3%40.6%1.1%Jun 2026
Jul 202619.4%32.5%44.2%0.0%Jun 2026
Jun 202624.5%22.4%48.2%0.0%Dec 2025
May 202624.9%21.9%47.7%0.0%Dec 2025
Apr 202624.6%23.8%46.9%0.0%Dec 2025
Mar 202625.0%26.7%47.0%0.0%Dec 2025
Feb 202624.9%25.9%47.4%0.0%Dec 2025
Jan 202624.0%26.0%48.8%0.0%Dec 2025
Dec 202531.6%24.9%39.7%3.2%Jun 2025
Nov 202532.6%23.9%39.1%3.1%Jun 2025
Sources: UTI Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 12 months29.8%Oct 2025 to Oct 2026 · bought ₹510 cr, sold ₹351 cr
MonthBoughtSoldTurnover
Oct 2026₹102 cr₹20.4 cr1.5%
Sep 2026₹72.4 cr₹36.9 cr2.7%
Aug 2026₹57.1 cr₹53.6 cr4.0%
Jul 2026₹55.5 cr₹9.5 cr0.7%
Jun 2026₹32.0 cr₹13.5 cr1.1%
May 2026₹39.6 cr₹37.1 cr3.3%
Apr 2026₹11.3 cr₹51.3 cr1.1%
Mar 2026₹26.1 cr₹21.3 cr2.0%
Feb 2026₹33.3 cr₹37.1 cr3.1%
Jan 2026₹17.3 cr₹25.3 cr1.6%
Dec 2025₹33.3 cr₹25.1 cr2.3%
Nov 2025₹30.7 cr₹20.4 cr1.8%
Source: UTI Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns next to the benchmark

What the plan's NAV did over each period, as AMFI publishes it.

as of 19 Nov 2026 · as published by AMFI
PeriodDirect planRegular planBenchmark, as published by AMFI BSE Healthcare TRI
1 year+22.03 %+20.89 %+19.11 %
3 years+23.06 %+21.87 %+22.11 %
5 years+17.74 %+16.55 %+16.69 %
10 years+15.88 %+14.73 %+13.98 %
Since launch+16.52 %+14.88 %+15.09 %

Past performance may not be sustained in future.

Source: AMFI fund performance

As AMFI's fund performance report prints them for "UTI Healthcare Fund"; this site computes no benchmark figure of its own.

How to read

How it is computed: NAV to NAV

UTI - Healthcare Fund - Direct Plan - Growth: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.

PeriodReturnFromTo
1 year+22.75 % in total 20 Nov 2025 · NAV ₹327.367520 Nov 2026 · NAV ₹401.8398
3 years+23.24 % a year, compounded 20 Nov 2023 · NAV ₹214.578920 Nov 2026 · NAV ₹401.8398
5 years+17.91 % a year, compounded 18 Nov 2021 · NAV ₹176.080720 Nov 2026 · NAV ₹401.8398
Since first NAV+16.58 % a year, compounded 2 Jan 2013 · NAV ₹47.720020 Nov 2026 · NAV ₹401.8398

Source: AMFI NAV files (plan code 120782). How to read Report a wrong number

IDCW (dividend) history

0 declarations · as of 28 Oct 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Rolling returns, UTI - Healthcare Fund - Direct Plan - Growth

weekly NAVs · Source: AMFI
WindowLowestMedianHighestWindows above zero
1 year in total −16.25 % 7 Sep 2018 to 13 Sep 2019+13.56 % 12 Mar 2021 to 17 Mar 2022+84.79 % 27 Mar 2020 to 1 Apr 2021 69 % of 664 windows ending 10 Jan 2014 to 20 Nov 2026
3 years a year, compounded −5.93 % 23 Oct 2015 to 26 Oct 2018+17.94 % 15 Sep 2017 to 18 Sep 2020+29.25 % 19 May 2023 to 22 May 2026 84 % of 568 windows ending 8 Jan 2016 to 20 Nov 2026
5 years a year, compounded −3.71 % 27 Mar 2015 to 27 Mar 2020+13.59 % 27 May 2016 to 28 May 2021+31.89 % 11 Oct 2019 to 11 Oct 2024 99 % of 463 windows ending 5 Jan 2018 to 20 Nov 2026

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

Every 1-, 3- and 5-year window ending on a week's last NAV, lowest, middle and highest.

Volatility, a year

Standard deviation of weekly NAV changes × √52. 24 Nov 2023 to 20 Nov 2026, 156 weekly changes.

Source: AMFI

14.39 %156 weeks to 20 Nov 2026
Largest fall from a high

High 21 Aug 2015, low 11 Oct 2019; back at the high 24 Apr 2020.

Weekly NAVs since 4 Jan 2013. Measured on each week's last NAV, so a fall within a week can be deeper than shown.

Source: AMFI

−23.64 %low 11 Oct 2019

Past performance may not be sustained in future.

Next to its category: Sectoral or thematic

weekly NAVs · Source: AMFI
Rolling windowLower quarterUpper quarterAbove 6 %Above 9 %Above 12 %Above the category average
1 year−2.4 %+37.9 % 57.7 %54.8 %51.5 % 45.8 % of 664 windows
3 years+5.6 %+23.9 % 74.6 %73.4 %70.8 % 50.4 % of 568 windows
5 years+9.9 %+17.2 % 85.5 %77.8 %66.1 % 36.9 % of 463 windows
How this is counted

Same windows as the rolling returns above. A quarter of the windows returned less than the lower quarter, and a quarter more than the upper. "Above" columns give the share of windows. The category average is the average for windows ending the same week.

Market phases

PhaseDatesThis schemeCategory average
Slowdown, 2015–1627 Feb 2015 to 26 Feb 2016 in total−1.3 %−15.8 % 48 schemes
Rise, 2016–1826 Feb 2016 to 31 Aug 2018 a year, compounded+4.8 %+23.7 % 55 schemes
To the COVID low31 Aug 2018 to 27 Mar 2020 a year, compounded−12.1 %−17.8 % 58 schemes
Rise from the COVID low27 Mar 2020 to 27 Sep 2024 a year, compounded+35.8 %+37.3 % 70 schemes
Foreign selling, 2024–2527 Sep 2024 to 28 Feb 2025 in total−14.2 %−19.1 % 148 schemes
Since March 202528 Feb 2025 to 20 Nov 2026 a year, compounded+23.6 %+15.6 % 165 schemes

The phases are the site's own split of the market since 2015, measured from month end to month end.

From each quarter end to the newest NAV

FromDatesThis schemeCategory average
From Jun 202625 Jun 2026 to 20 Nov 2026 in total+10.1 %+4.6 % 195 schemes
From Mar 202627 Mar 2026 to 20 Nov 2026 in total+28.6 %+18.1 % 195 schemes
From Dec 202526 Dec 2025 to 20 Nov 2026 in total+24.9 %+6.8 % 188 schemes
From Sep 202526 Sep 2025 to 20 Nov 2026 a year, compounded+21.2 %+8.9 % 182 schemes
From Jun 202527 Jun 2025 to 20 Nov 2026 a year, compounded+17.9 %+6.0 % 173 schemes
From Mar 202528 Mar 2025 to 20 Nov 2026 a year, compounded+19.0 %+11.9 % 169 schemes
From Dec 202427 Dec 2024 to 20 Nov 2026 a year, compounded+11.6 %+5.8 % 159 schemes
From Sep 202427 Sep 2024 to 20 Nov 2026 a year, compounded+10.4 %+1.6 % 148 schemes
From Jun 202428 Jun 2024 to 20 Nov 2026 a year, compounded+19.4 %+5.4 % 139 schemes
From Mar 202428 Mar 2024 to 20 Nov 2026 a year, compounded+19.9 %+9.9 % 133 schemes
From Dec 202329 Dec 2023 to 20 Nov 2026 a year, compounded+21.6 %+11.6 % 127 schemes
From Sep 202329 Sep 2023 to 20 Nov 2026 a year, compounded+23.7 %+14.6 % 118 schemes
Spread of falling weeks, a year

Root mean square of the weekly falls × √52 (rising weeks count as zero).

9.0 %24 Nov 2023 to 20 Nov 2026
Up capture

Its average change in the 92 weeks the category average rose, as a share of the category's.

96.5 %92 rising weeks
Down capture

The same for the 64 weeks the category average fell.

72.4 %64 falling weeks

Past performance may not be sustained in future.

Source: AMFI NAV files.

Category average = the plain average for the other schemes in the same AMFI category with the same figure (direct growth plans, each week's last NAV). It is not an index, and the scheme's place among them is not shown. Peers are today's schemes in today's category, so a scheme that has closed is not in the average, and SEBI re-sorted the categories in 2018.

52-week high NAV

Highest and lowest of 248 daily NAVs, 20 Nov 2025 to 20 Nov 2026, UTI - Healthcare Fund - Direct Plan - Growth.

Source: AMFI

₹401.839820 Nov 2026
52-week low NAV₹304.484129 Jan 2026

Calendar-year returns, UTI - Healthcare Fund - Direct Plan - Growth

NAV to NAV · Source: AMFI
YearReturnFromTo
2025−2.18 % 31 Dec 2024 · NAV ₹328.768531 Dec 2025 · NAV ₹321.5996
2024+44.27 % 29 Dec 2023 · NAV ₹227.884331 Dec 2024 · NAV ₹328.7685
2023+39.56 % 30 Dec 2022 · NAV ₹163.285529 Dec 2023 · NAV ₹227.8843
2022−11.30 % 31 Dec 2021 · NAV ₹184.087630 Dec 2022 · NAV ₹163.2855
2021+20.35 % 31 Dec 2020 · NAV ₹152.964031 Dec 2021 · NAV ₹184.0876
2020+68.92 % 31 Dec 2019 · NAV ₹90.554631 Dec 2020 · NAV ₹152.9640
2019+2.17 % 31 Dec 2018 · NAV ₹88.632031 Dec 2019 · NAV ₹90.5546
2018−6.54 % 29 Dec 2017 · NAV ₹94.833431 Dec 2018 · NAV ₹88.6320
2017+7.18 % 30 Dec 2016 · NAV ₹88.477329 Dec 2017 · NAV ₹94.8334
2016−8.89 % 31 Dec 2015 · NAV ₹97.105230 Dec 2016 · NAV ₹88.4773

Past performance may not be sustained in future.

Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read

Monthly SIP of ₹10,000, UTI - Healthcare Fund - Direct Plan - Growth

XIRR · Source: AMFI
PeriodInstalmentsPaid inValueXIRR, a year
1 year 1 Dec 2025 to 2 Nov 202612 ₹1,20,000₹1,39,793 20 Nov 2026 · NAV ₹401.8398+33.95 %

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Portfolios most like this one, Oct 2026

same category, other fund houses
Most alike and most unique funds →

Overlap is the sum, over stocks both hold, of the smaller of the two weights. A measured likeness, not a suggestion to switch.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

Questions about UTI - Healthcare Fund

from the figures on this page

What are the top holdings of UTI - Healthcare Fund?

At Oct 2026 end, UTI - Healthcare Fund held 46 stocks (98.0% of the fund in equity). Largest: Sun Pharmaceutical Industries 7.44%, Divi's Laboratories 6.46%, Dr. Reddy's Laboratories 5.78%, Ajanta Pharma 4.29%, Max Healthcare Institute 4.20%; the top 10 make up 46.6%. Funds holding Sun Pharmaceutical Industries · Funds holding Divi's Laboratories · Funds holding Dr. Reddy's Laboratories

What portfolio changes did UTI - Healthcare Fund make in Oct 2026?

Compared with Sep 2026, by share count: 2 new, 13 added, 6 trimmed, 0 exited. Largest by value: Sahajanand Medical Technologies (new), Natco Pharma (new), Dr. Reddy's Laboratories (added), Max Healthcare Institute (added).

Who manages UTI - Healthcare Fund?

AMFI's scheme summary document names Kamal Gada for UTI - Healthcare Fund (UTI Mutual Fund). Kamal Gada, fund manager portfolio

All schemes of UTI Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.